Diana Suciu

Diana Suciu

Auto-generated profile, based on publicly available information

Diana Suciu

Boston University, Department of Biomedical Engineering, Boston, Massachusetts, United States

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2025 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
DSDiana Suciu
Diana Suciu
TPThao Pham
Thao Pham
LWLina Lin Wei
Lina Lin Wei
SGShripreetika Guruprasad
Shripreetika Guruprasad
DRDarren Roblyer
Darren Roblyer
Diffuse optical spectroscopy (DOS) is a technique that leverages light propagation in highly scattering media to measure tissue optical properties. This technique is also commonly referred to as near-infrared spectroscopy (NIRS) when utilizing wavelengths in the near-infrared (NIR) region (∼650 to 1000 nm). DOS and NIRS have been widely applied in medical diagnostics in applications ranging from cancer to neuroscience.1 Three types of NIRS modalities are commonly used in biological measurements: continuous wave (CW), frequency domain (FD), and time domain (TD).1 – 3 Among these techniques, only FD-NIRS and TD-NIRS allow for the decoupling of absolute absorption (μa) and reduced scattering (μs′) from the measured optical signal.4 Specifically, for FD-NIRS, the absolute measurements of both μa and μs′ can be achieved using calibrated amplitude and phase information of the detected light after traveling through tissue.1,5 One of the limitations of FD-NIRS is the added instrumental complexity compared with CW-NIRS, which typically restricts absolute measurements of optical properties to only a few wavelengths simultaneously. To address this, hybrid FD + CW systems have been developed to acquire absolute broadband μa and μs′ spectra.5 – 7 Though prior NIRS techniques have focused on quantifying oxygenated and deoxygenated hemoglobin (HbO2 and Hb, respectively),1,2 there has been a growing interest over the last decade in using diffuse optical techniques to measure tissue concentrations of water and lipids.8 – 11

1 January 2026 in Biophotonics Discovery
Verified
Journal Article
Open access
DSDiana Suciu
Diana Suciu
TPThao Pham
Thao Pham
LWLina Lin Wei
Lina Lin Wei
IHIsaac Hoekstra
Isaac Hoekstra
PYPranav Yadati
Pranav Yadati
DRDarren Roblyer
Darren Roblyer
SignificancePoor fluid management during hemodialysis in patients with end-stage kidney disease contributes to adverse clinical outcomes. Current tools for assessing volume status are limited, and there is a need for objective measurement techniques.AimWe aim to evaluate the ability of a hybrid frequency-domain (FD) and broadband continuous-wave near-infrared spectroscopy (FD-Bb-NIRS) system to monitor tissue changes during hemodialysis and identify markers associated with intradialytic adverse events.ApproachA custom-built FD-Bb-NIRS system was used to acquire continuous optical measurements. The system utilized FD laser diodes (730, 785, 852, and 940 nm) and broadband illumination (700 to 1000 nm). These measurements were integrated using model-based analysis to provide broadband absorption and reduced scattering spectra. Beer’s law was used to extract tissue chromophore concentrations.ResultsAcross 27 subjects, the water ratio ([water]/([water] + [lipid])) showed significant differences between subjects with and without intradialytic adverse events (p=0.0331), with a decrease observed in patients without adverse events. In addition, tissue scattering parameters contributed to the multivariate classification of adverse event discrimination.ConclusionsThe FD-Bb-NIRS device successfully measured changes in tissue fluid dynamics during hemodialysis. Longitudinal water ratio measurements show promise as optical markers for identifying patients at risk of adverse events.